3,5-Dimethylpiperidine → 4-(2-Butynyloxy)-6-(3,5-dimethylpiperidino)pyrimidine

HRID 14518

Reaktionsgleichung

Reaktionsgleichung von HRID 14518
[CH2:1]([O:5][C:6]1[CH:11]=[C:10](Cl)[N:9]=[CH:8][N:7]=1)[C:2]#[C:3][CH3:4].[CH3:13][CH:14]1[CH2:19][CH:18]([CH3:20])[CH2:17][NH:16][CH2:15]1>C(O)C>[CH2:1]([O:5][C:6]1[CH:11]=[C:10]([N:16]2[CH2:17][CH:18]([CH3:20])[CH2:19][CH:14]([CH3:13])[CH2:15]2)[N:9]=[CH:8][N:7]=1)[C:2]#[C:3][CH3:4]

Komponenten

4

Versuchsvorschrift

Into 3 ml of ethanol was resolved 0.3 g of 4-(2-butynyloxy)-6-chloropyrimidine, 0.56 g of 3,5-dimethylpiperidine (cis/trans=about 3/1) was added therein, and the mixture was stirred for 10 hours under reflux condition. The reaction mixture was cooled to near room temperature, and concentrated. Into the residue was added a saturated ammonium chloride aqueous solution, and the mixture was extracted with tert-butyl methyl ether three times. The organic layers were washed with a saturated sodium chloride aqueous solution, dried over anhydrous magnesium sulfate and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.44 g of 4-(2-butynyloxy)-6-(3,5-dimethylpiperidino)pyrimidine (hereinafter, referred to as Compound (7)). Compound (7) had the cis/trans diastereomer originated two methyls on the piperidine ring. The ratio of the cis/trans diastereomer was about 3.1/1.

Aufarbeitung

  1. additionwas added
  2. temperatureunder reflux condition
  3. concentrationconcentrated
  4. additionInto the residue was added a saturated ammonium chloride aqueous solution
  5. extractionthe mixture was extracted with tert-butyl methyl ether three times
  6. washThe organic layers were washed with a saturated sodium chloride aqueous solution
  7. dry with materialdried over anhydrous magnesium sulfate
  8. concentrationconcentrated

Quellen und Nachweise

ORD-Eintrag
ord-7a3ccfd589044048959aa82f42046d67
Quelldatensatz
uspto-grants-2010_06
Patentnummer
US07732448B2

Verknüpfte Notizen

Wird geladen…